Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112898192B details a novel palladium-catalyzed carbonylation method for N-acyl indoles, offering cost reduction in API manufacturing and scalable production.
Discover a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrole-2-one compounds. Efficient, scalable synthesis for pharmaceutical intermediates.
Novel carbonylation route for pyrrol-2-one scaffolds offers high efficiency and substrate tolerance for pharmaceutical manufacturing.
Patent CN113880781B details biomass-based synthesis. Offers cost reduction and supply chain stability for pharmaceutical intermediate manufacturing globally.
Patent CN105175327B reveals high-purity quinoline synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN114920707B reveals a novel iodine-catalyzed route using DMF as a carbon source for high-purity 1,2,4-triazole derivatives, offering significant cost reduction in API manufacturing.
Novel Ag-catalyzed route for 9,10-phenanthrene dicarboxylic esters offers mild conditions and high purity for reliable pharmaceutical intermediate supply chains.
Novel Pd-catalyzed route for 3-arylquinolin-2(1H)-ones using benzisoxazole. High yield, scalable process for pharmaceutical intermediates.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN116023359A reveals a breakthrough copper-catalyzed amination route for aminothiophenes, offering superior yields and safety over traditional nitration for pharmaceutical supply chains.
Patent CN111925356B details a novel chiral quinoline-imidazoline ligand enabling high-yield nickel-catalyzed synthesis of chiral lactams for pharmaceutical intermediates.
Patent CN116199614B reveals high ee synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN110156710B details a novel Pd-catalyzed route for polysubstituted oxazoles. Discover cost-effective manufacturing and supply chain advantages for API intermediates.
Novel glucose-based route for trifluoromethyl triazoles. Mild conditions, scalable, cost-effective pharmaceutical intermediates manufacturing solution.
Patent CN110156710B details a scalable Pd-catalyzed route for polysubstituted oxazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN109293491B details a metal-free photochemical acylation method. Offers high yields up to 72% for pharmaceutical intermediates without transition metals.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN115850178B reveals high-purity synthesis for agrochemical intermediates. Enhanced selectivity reduces costs and ensures supply chain reliability for global buyers.
Novel Pd-catalyzed carbonylation method for 2-CF3 imidazoles offers high yield and scalability for reliable pharmaceutical intermediate supply chains.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles offers cost-effective, scalable routes for API intermediates without heavy metals.